Seres teams up with AstraZeneca to explore microbiome benefits in cancer treatment
March 11, 2019 at 12:58 PM EDT
Microbiome-focused biotech Seres Therapeutics is teaming up with drug giant AstraZeneca to explore how the trillions of bacteria in a person’s gut could help fight cancer.